Description

Erlocip 150 mg contains Erlotinib and belongs to a class of medications called kinase inhibitors. Erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase, which is highly expressed and occasionally mutated in various forms of cancer. Erlotinib hydrochloride Tablets has shown a survival benefit in the treatment of lung cancer manufactured by CIPLA Which is serving the healthcare industry with the vision to make medicines affordable and accessible, particularly anti-cancer medication. Brand Name: Erlocip 150mg Generic Name: Erlotinib Tablets Contents: Erlotinib 150mg Form: Tablets Manufacturer Cipla India Ltd Packing: Pack of 30 tabs